EFFECT OF OZANIMOD TREATMENT AND DISCONTINUATION ON ABSOLUTE LYMPHOCYTE COUNT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM A PHASE 3 RANDOMIZED TRIAL
Geert R. D'Haens 1
Peter Irving 2
Jean-Frédéric Colombel 3
AnnKatrin Petersen 4
Denesh Chitkara
Cecilia Marta
Tianlei Chen
Lorna Charles
Silvio Danese 5
Subrata Ghosh 6
1 Amsterdam University Medical Centers, Amsterdam, Netherlands
2 IBD Centre, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
3 Icahn School of Medicine at Mount Sinai, New York, United States
4 Bristol Myers Squibb Company, Princeton, United States
5 Inflammatory Bowel Diseases Center, Humanitas Clinical and Research Center IRCCS and Hunimed, Milan, Italy
6 APC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland
Session
IBD (Posters)
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]